Skip to main content
. Author manuscript; available in PMC: 2009 Sep 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2008 Sep;14(9):1017–1021. doi: 10.1016/j.bbmt.2008.06.013

Table 4.

Survival at 100 days, 1 year, and 2 years from HCT

Survival
N # dead 100 day survival (95% CI) 1 year (95% CI) P 2 year (95% CI) P
Total 98 49 83% (76–90%) 59% (49–69%) 50% (40–60%)
Palifermin 67 36 82% (73–91%) 58% (46–70%) .85 46% (34–58%) .42
 Placebo 31 13 84% (71–97%) 61% (44–78%) 58% (41–75%)